Limited reproducibility of MUCH and WUCH: evidence from the ELSA study - PubMed (original) (raw)
. 2020 Apr 21;41(16):1565-1571.
doi: 10.1093/eurheartj/ehz651.
Affiliations
- PMID: 31539054
- DOI: 10.1093/eurheartj/ehz651
Limited reproducibility of MUCH and WUCH: evidence from the ELSA study
Giuseppe Mancia et al. Eur Heart J. 2020.
Abstract
Aims: To evaluate the long-term reproducibility of masked (MUCH) and white-coat uncontrolled hypertension (WUCH), an information crucial for determining the long-term prognostic impact of these conditions.
Methods and results: Reproducibility of MUCH and WUCH was assessed in 1664 hypertensive patients recruited for the European Lacidipine Study on Atherosclerosis and treated with atenolol or lacidipine (±additional drugs) during a 4-year period. Office and 24 h blood pressure (BP) was measured at baseline and every year during treatment, allowing repeated classification of either condition. After 1 year of treatment 21.1% and 17.8% of the patients were classified as MUCH and WUCH, respectively. For both conditions the prevalence was similar in the following years, although with a large change in patients composition because only about 1/3 of patients classified as MUCH or WUCH at one set of office and ambulatory BP measurements maintained the same classification at a subsequent set of measurements. In only 4.5% and 6.2% MUCH and WUCH persisted throughout the treatment period. MUCH and WUCH reproducibility was worse than that of patients showing control or lack of control of both office and ambulatory BP, i.e. controlled and uncontrolled hypertension, respectively.
Conclusion: Both MUCH and WUCH display poor reproducibility over time. This should be taken into account in studies assessing the long-term prognostic value of these conditions based on only one set of BP measurements.
Keywords: Antihypertensive treatment; Blood pressure; Masked uncontrolled hypertension; White-coat uncontrolled hypertension.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
Comment in
- Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH.
Kjeldsen SE, Os I. Kjeldsen SE, et al. Eur Heart J. 2020 Apr 21;41(16):1572-1574. doi: 10.1093/eurheartj/ehz703. Eur Heart J. 2020. PMID: 31580419 No abstract available.
Similar articles
- Reproducibility of blood pressure phenotypes identified by office and ambulatory blood pressure in treated hypertensive patients. Data from the PHYLLIS study.
Mancia G, Facchetti R, Vanoli J, Dolfini V, Grassi G. Mancia G, et al. Hypertens Res. 2022 Oct;45(10):1599-1608. doi: 10.1038/s41440-022-00982-5. Epub 2022 Aug 8. Hypertens Res. 2022. PMID: 35941356 Review. - White Coat Uncontrolled Hypertension in Teleconsultation: A New and Frequent Entity.
Barochiner J, Marín MJ, Janson JJ, Conti PR, Martínez R, Micali G, Conte IE, Plazzotta F. Barochiner J, et al. High Blood Press Cardiovasc Prev. 2022 Mar;29(2):155-161. doi: 10.1007/s40292-021-00498-y. Epub 2021 Dec 14. High Blood Press Cardiovasc Prev. 2022. PMID: 34905157 Free PMC article. - Prognostic role of masked and white-coat hypertension: 10-Year mortality in treated elderly hypertensives.
Spannella F, Filipponi A, Giulietti F, Balietti P, Bernardi B, Rosettani G, Sarzani R. Spannella F, et al. J Hum Hypertens. 2019 Oct;33(10):741-747. doi: 10.1038/s41371-018-0140-4. Epub 2018 Dec 5. J Hum Hypertens. 2019. PMID: 30518804 - Blood pressure phenotype reproducibility in CKD outpatients: a clinical practice report.
Cupisti A, Bruno RM, Puntoni A, Varricchio E, Giglio E, Meniconi O, Zullo C, Barsotti M, Egidi MF, Ghiadoni L. Cupisti A, et al. Intern Emerg Med. 2020 Jan;15(1):87-93. doi: 10.1007/s11739-019-02127-y. Epub 2019 Jun 17. Intern Emerg Med. 2020. PMID: 31209681 - The HOPE Asia Network consensus on blood pressure measurements corresponding to office measurements: Automated office, home, and ambulatory blood pressures.
Shin J, Wang JG, Chia YC, Kario K, Chen CH, Cheng HM, Fujiwara T, Hoshide S, Huynh MV, Li Y, Nagai M, Nailes J, Park S, Siddique S, Sison J, Soenarta AA, Sogunuru GP, Tay JC, Teo BW, Tomitani N, Tsoi K, Turana Y, Verma N, Wang TD, Zhang Y. Shin J, et al. J Clin Hypertens (Greenwich). 2023 Oct 25. doi: 10.1111/jch.14729. Online ahead of print. J Clin Hypertens (Greenwich). 2023. PMID: 37878534 Review.
Cited by
- Hypertension and Cardiovascular Risk Among Children with Chronic Kidney Disease.
Larkins NG, Craig JC. Larkins NG, et al. Curr Hypertens Rep. 2024 Oct;26(10):389-398. doi: 10.1007/s11906-024-01308-1. Epub 2024 May 28. Curr Hypertens Rep. 2024. PMID: 38806767 Free PMC article. Review. - White Coat Hypertension & Cardiovascular Outcomes.
Townsend RR, Cohen JB. Townsend RR, et al. Curr Hypertens Rep. 2024 Oct;26(10):399-407. doi: 10.1007/s11906-024-01309-0. Epub 2024 May 18. Curr Hypertens Rep. 2024. PMID: 38761349 Free PMC article. Review. - The role of wearable home blood pressure monitoring in detecting out-of-office control status.
Pan HY, Lee CK, Liu TY, Lee GW, Chen CW, Wang TD. Pan HY, et al. Hypertens Res. 2024 Apr;47(4):1033-1041. doi: 10.1038/s41440-023-01539-w. Hypertens Res. 2024. PMID: 38242946 Free PMC article. - Masked Hypertension and Exaggerated Blood Pressure Response to Exercise: A Review and Meta-Analysis.
Cuspidi C, Gherbesi E, Faggiano A, Sala C, Carugo S, Grassi G, Tadic M. Cuspidi C, et al. Diagnostics (Basel). 2023 Mar 7;13(6):1005. doi: 10.3390/diagnostics13061005. Diagnostics (Basel). 2023. PMID: 36980313 Free PMC article. Review. - The long-term reproducibility of the white-coat effect on blood pressure as a continuous variable from the Ohasama Study.
Satoh M, Yoshida T, Metoki H, Murakami T, Tatsumi Y, Hirose T, Takabatake K, Tsubota-Utsugi M, Hara A, Nomura K, Asayama K, Kikuya M, Hozawa A, Imai Y, Ohkubo T. Satoh M, et al. Sci Rep. 2023 Mar 27;13(1):4985. doi: 10.1038/s41598-023-31861-9. Sci Rep. 2023. PMID: 36973366 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical